Bladder Cancer Awareness Day 🎗️ Hematuria should never be ignored. Early evaluation saves lives. At Urology Group Aalst, we offer 20 years of expertise in minimally invasive bladder cancer care, with tailored treatments for every patient. mdpi.com/2072-6694/17/18/306…

🔥 Tremendous week for Urology Group Aalst at AZORG 🔥 🥇First Belgian tele-proctoring RARP by Dr. Geert De Naeyer & Dr. Frederiek D'Hondt 🥇 First AI-supported RAPN by Prof. Dr. Alex Mottrie & Dr. Ir. Pieter De Backer vrt.be/vrtnws/nl/kijk/2026/0…

In cisplatin-ineligible patients with muscle-invasive bladder cancer, enfortumab vedotin–pembrolizumab plus surgery led to better event-free survival (74.7%, vs. 39.4%) and overall survival (79.7%, vs. 63.1%) than surgery alone at 2 years. Full phase 3 KEYNOTE-905/EV-303 trial results: nej.md/4czl8sG Editorial: Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy nej.md/4twnv5T

One month ago, Edward Lambert successfully defended his PhD thesis, focusing on optimizing outcomes for patients with localized or metastatic prostate cancer. This achievement reflects UGA's ongoing commitment to advancing knowledge and improving patient care.

Proud of our two colleagues Prof. Dr. Alex Mottrie and Dr. Ir. Pieter De Backer for their achievements as pioneers in AI driven surgery. The future of surgery is being built here! 🦾🩺 link.msgsndr.com/sp/e40fcd1e… #DataDriven #ORSI #AI #Innovation #DeTijd #AalstUrologyGroup

Dr. Ir. Pieter De Backer has joined the Aalst Urology Group as the 13th member of the team. As a urologist and engineer, he is considered an international expert in innovation and AI-driven surgical support. He will mainly focus on surgical innovation and robot-assisted surgery.

@UAalst6631 Welcome to UGA – Urology Group Aalst! 🩺 13 superspecialised urologists • All subdisciplines • 6 campuses. 25y Robotics | 15y HOLEP | 8y REZUM | integrated uro-oncology. Pioneers in Aquablation, AI-assisted surgery & tele-surgery. 450 pubs. TopCare. Forwardism.

I smile: when one contributes data that even minimally challenge the idea of #radiotherapy as uneventful, it is dismissed as “narrative”; yet in some RCTs (PACE-A), reporting 50% incontinence at 2 years after #prostatectomy is called “data”.

Congrats 🎊 @EdwLambert it was a huge step forward and your work on #prostate #cancer has really been appreciated we will remember it not only for the quality of your data but also for the weather conditions ❄️

Earlier this week, I successfully defended my PhD, marking the conclusion of a long and rigorous doctoral journey. Grateful to my promotors Charles Van Praet and Nicolaas Lumen, and to all jury members, for their guidance and critical insights. Looking ahead to new challenges!

Great day of sharing experience and insights on bladder cancer surgery. Honoured to be part of the expert panel discussion on advancing intracorporeal robotic neobladder surgery in Perugia 🇮🇹 🤖 Special thanks to Prof. @RoccoPapaliaUro @AalstOlv @alexmottrie

🛜🥇🤖First teleproctoring case in Europe: Robot-assisted radical prostatectomy tele-surgery with two sugeons 600 kms apart as a live-case for the German Society for Robot-Assisted Urology #DRUS congress 🇩🇪. @gdnaeyer @alexmottrie @MicroPort #Toumai youtube.com/watch?v=XfhQRd6y…

pCR rate of 57% after NA EV P in Cis ineligble BCa patients. How will we select those who can preserve their bladder? Exciting data presented by @cvulsteke at #ESMO25 #bladdercancer

KN905 Very impressive results with neoadjuvant EV-P in cisplatin-ineligible muscle invasive #bladdercancer presented by C Vulsteke at #ESMO25 ✅Improved PFS & OS ✅High path CR rates (57%) ✅No delay in surgery ✅Expected toxicity in this frail population New SOC

1/2 KN905 Enfortumab Vedotin Pembro continues to transform bladder cancer in spectacle fashion. In cisplatin ineligible operable disease it beats cystectomy with EFS HR 0.4, OS HR 0.5. pCR of 57% is much ⬆️ than anything before #ESMO25 pCR> 50% questions unselected surgery

🔥Very exciting talk on the future of advanced prostate cancer treatment by Gerhardt Attard & @UrsulaVogl at #ESMO25 #ProstateCancer

Check our latest article on #ERAS for radical cystectomy!! HUGE effort from all the group 👏 @albisinnidoc & @andreamari08 @EAUYAUrology @Uroweb @eau_yuo

Very happy and honoured to have shared our insights from @AalstOlv on robot-assisted cystectomy with neobladder at this wonderfull first RARC - neobladder masterclass. Hope to see you again next year!

Preparing for robot-assisted simple prostatectomy @OLVZaalst @AalstOlv on a 230 ml prostate for #ERUS24. @ERUSrobotics @Ruben_De_Groote @alexmottrie @gdnaeyer

Let's break the silence, challenge the stigma, and prioritize men's health this month and beyond. Together, we can make a difference. Laten we het zwijgen doorbreken, stigma wegwerken & de gezondheid van mannen deze maand en daarna prioriteit geven. Samen maken we het verschil💙